Drug-induced gynecomastia: an evidence-based review

Bibliography

• Braunstein GD. Clinical practice. Gynecomastia N Engl J Med 2007;357(12):1229-37
   PubMedGoogle Scholar
• Mathur R, Braunstein GD. Gynecomastia: pathomechanisms and treatment strategies. Horm Res 1997;48(3):95-102
   PubMed Web of Science ®Google Scholar
• Braunstein GD. Gynecomastia. N Engl J Med 1993;328(7):490-5
   PubMed Web of Science ®Google Scholar
• Thompson DF, Carter JR. Drug-induced gynecomastia. Pharmacotherapy 1993;13(1):37-45
   PubMed Web of Science ®Google Scholar
• Eckman A, Dobs A. Drug-induced gynecomastia. Expert Opin Drug Saf 2008;7(6):691-702
   PubMed Web of Science ®Google Scholar
• Hill AB. The environment and disease: association or causation/? Proc R Soc Med 1965;58:295-300
   PubMed Web of Science ®Google Scholar
• U.S. Preventive Services Task Force Evidence Syntheses, formerly Systematic Evidence Reviews - NCBI Bookshelf [Internet]. Available from: http://www.ncbi.nlm.nih.gov.mlprox.csmc.edu/books/NBK43437/ [Cited 15 Dec 2011]
   Google Scholar
• Guirguis-Blake J, Calonge N, Miller T, Current processes of the U.S. Preventive Services Task Force: refining evidence-based recommendation development. Ann Intern Med 2007;147(2):117-22
   PubMed Web of Science ®Google Scholar
• Huffman DH, Kampmann JP, Hignite CE, Gynecomastia induced in normal males by spironolactone. Clin Pharmacol Ther 1978;24(4):465-73
   PubMed Web of Science ®Google Scholar
• Caminos-Torres R, Ma L, Snyder PJ. Gynecomastia and semen abnormalities induced by spironolactone in normal men. J Clin Endocrinol Metab 1977;45(2):255-60
   PubMed Web of Science ®Google Scholar
• Pitt B, Zannad F, Remme WJ, The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341(10):709-17
   PubMed Web of Science ®Google Scholar
• Rose LI, Underwood RH, Newmark SR, Pathophysiology of spironolactone-induced gynecomastia. Ann Intern Med 1977;87(4):398-403
   PubMed Web of Science ®Google Scholar
• Spence RW, Celestin LR. Gynaecomastia associated with cimetidine. Gut 1979;20(2):154-7
   PubMed Web of Science ®Google Scholar
• Jensen RT, Collen MJ, McArthur KE, Comparison of the effectiveness of ranitidine and cimetidine in inhibiting acid secretion in patients with gastric hypersecretory states. Am J Med 1984;77(5B):90-105
   PubMed Web of Science ®Google Scholar
• García Rodríguez LA, Jick H. Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs. BMJ 1994;308(6927):503-6
   PubMed Web of Science ®Google Scholar
• Funder JW, Mercer JE. Cimetidine, a histamine H2 receptor antagonist, occupies androgen receptors. J Clin Endocrinol Metab 1979;48(2):189-91
   PubMed Web of Science ®Google Scholar
• Galbraith RA, Michnovicz JJ. The effects of cimetidine on the oxidative metabolism of estradiol. N Engl J Med 1989;3321(5):269-74
   PubMed Web of Science ®Google Scholar
• Lardinois CK, Mazzaferri EL. Cimetidine blocks testosterone synthesis. Arch Intern Med 1985;145(5):920-2
   PubMed Web of Science ®Google Scholar
• DeFelice R, Johnson DG, Galgiani JN. Gynecomastia with ketoconazole. Antimicrob Agents Chemother 1981;19(6):1073-4
   PubMed Web of Science ®Google Scholar
• Sugar AM, Alsip SG, Galgiani JN, Pharmacology and toxicity of high-dose ketoconazole. Antimicrob Agents Chemother 1987;31(12):1874-8
   PubMed Web of Science ®Google Scholar
• Pont A, Graybill JR, Craven PC, High-dose ketoconazole therapy and adrenal and testicular function in humans. Arch Intern Med 1984;144(11):2150-3
   PubMed Web of Science ®Google Scholar
• Pont A, Williams PL, Azhar S, Ketoconazole blocks testosterone synthesis. Arch Intern Med 1982;142(12):2137-40
   PubMed Web of Science ®Google Scholar
• Pont A, Goldman ES, Sugar AM, Ketoconazole-induced increase in estradiol-testosterone ratio. Probable explanation for gynecomastia. Arch Intern Med 1985;Aug145(8):1429-31
   PubMed Web of Science ®Google Scholar
• Grosso DS, Boyden TW, Pamenter RW, Ketoconazole inhibition of testicular secretion of testosterone and displacement of steroid hormones from serum transport proteins. Antimicrob Agents Chemother 1983;23(2):207-12
   PubMed Web of Science ®Google Scholar
• Liu H, Bravata DM, Olkin I, Systematic review: the safety and efficacy of growth hormone in the healthy elderly. Ann Intern Med 2007;146(2):104-15
   PubMed Web of Science ®Google Scholar
• Rudman D, Feller AG, Cohn L, Effects of human growth hormone on body composition in elderly men. Horm Res 1991;36(Suppl 1):73-81
   PubMed Web of Science ®Google Scholar
• Sullivan DH, Carter WJ, Warr WR, Side effects resulting from the use of growth hormone and insulin-like growth factor-I as combined therapy to frail elderly patients. J. Gerontol. A Biol Sci Med Sci 1998;53(3):M183-7
   Google Scholar
• Rudman D, Feller AG, Nagraj HS, Effects of human growth hormone in men over 60 years old. N Engl J Med 1990;323(1):1-6
   PubMed Web of Science ®Google Scholar
• Rosenbaum M, Gertner JM, Leibel RL. Effects of systemic growth hormone (GH) administration on regional adipose tissue distribution and metabolism in GH-deficient children. J Clin Endocrinol Metab 1989;69(6):1274-81
   PubMed Web of Science ®Google Scholar
• Ng ST, Zhou J, Adesanya OO, Growth hormone treatment induces mammary gland hyperplasia in aging primates. Nat Med 1997;3(10):1141-4
   PubMed Web of Science ®Google Scholar
• Burgués S, Calderón MD. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotropin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism. Hum Reprod 1997;12(5):980-6
   PubMedGoogle Scholar
• Schopohl J, Mehltretter G, von Zumbusch R, Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism. Fertil Steril 1991;56(6):1143-50
   PubMed Web of Science ®Google Scholar
• Forest MG, Lecoq A, Saez JM. Kinetics of human chorionic gonadotropin-induced steroidogenic response of the human testis. II. Plasma 17 alpha-hydroxyprogesterone, delta4-androstenedione, estrone, and 17 beta-estradiol: evidence for the action of human chorionic gonadotropin on intermediate enzymes implicated in steroid biosynthesis. J Clin Endocrinol Metab 1979;49(2):284-91
   PubMed Web of Science ®Google Scholar
• Harle LK, Maggio M, Shahani S, Endocrine complications of androgen-deprivation therapy in men with prostate cancer. Clin Adv Hematol Oncol 2006;4(9):687-96
   PubMedGoogle Scholar
• Thompson CA, Shanafelt TD, Loprinzi CL. Andropause: symptom management for prostate cancer patients treated with hormonal ablation. Oncologist 2003;8(5):474-87
   PubMed Web of Science ®Google Scholar
• Higano CS. Side effects of androgen deprivation therapy: monitoring and minimizing toxicity. Urology 2003;61(2 Suppl 1):32-8
   PubMedGoogle Scholar
• Hedlund PO. Side effects of endocrine treatment and their mechanisms: castration, antiandrogens, and estrogens. Prostate 2000;10(Suppl):32-7
   PubMedGoogle Scholar
• Mahler C, Denis L. Clinical profile of a new non-steroidal antiandrogen. J Steroid Biochem Mol Biol 1990;37(6):921-4
   PubMed Web of Science ®Google Scholar
• Wilton L, Pearce G, Edet E, The safety of finasteride used in benign prostatic hypertrophy: a non-interventional observational cohort study in 14,772 patients. Br J Urol 1996;78(3):379-84
   PubMedGoogle Scholar
• Green L, Wysowski DK, Fourcroy JL. Gynecomastia and breast cancer during finasteride therapy. N Engl J Med 1996;335(11):823
   PubMed Web of Science ®Google Scholar
• Ferrando J, Grimalt R, Alsina M, Unilateral gynecomastia induced by treatment with 1 mg of oral finasteride. Arch Dermatol 2002;138(4):543-4
   PubMed Web of Science ®Google Scholar
• Thompson IM, Goodman PJ, Tangen CM, The influence of finasteride on the development of prostate cancer. N Engl J Med 2003;349(3):215-24
   PubMed Web of Science ®Google Scholar
• Debruyne F, Barkin J, van Erps P, Efficacy and safety of long-term treatment with the dual 5 alpha-reductase inhibitor dutasteride in men with symptomatic benign prostatic hyperplasia. Eur Urol 2004;46(4):488-94; discussion 495
   PubMed Web of Science ®Google Scholar
• Szarfman A, Tonning JM, Levine JG, Atypical antipsychotics and pituitary tumors: a pharmacovigilance study. Pharmacotherapy 2006;26(6):748-58
   PubMed Web of Science ®Google Scholar
• Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs 2004;64(20):2291-314
   PubMed Web of Science ®Google Scholar
• Schlechte JA. Clinical practice. Prolactinoma N Engl J Med 2003;349(21):2035-41
   PubMedGoogle Scholar
• Melmed S, Casanueva FF, Hoffman AR, Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011;96(2):273-88
   PubMed Web of Science ®Google Scholar
• Sakiyama R, Quan M. Galactorrhea and hyperprolactinemia. Obstet Gynecol Surv 1983;38(12):689-700
   PubMedGoogle Scholar
• Carter JN, Tyson JE, Tolis G, Prolactin-screening tumors and hypogonadism in 22 men. N Engl J Med 1978;299(16):847-52
   PubMed Web of Science ®Google Scholar
• Tanner LA, Bosco LA. Gynecomastia associated with calcium channel blocker therapy. Arch Intern Med 1988;148(2):379-80
   PubMed Web of Science ®Google Scholar
• Boyd IW. Adverse drug reactions advisory committee. Gynaecomastia in association with calcium antagonists. Med J Aust 1994;161(5):328
   PubMed Web of Science ®Google Scholar
• Veldhuis JD, Borges JL, Drake CR, Divergent influences of the structurally dissimilar calcium entry blockers, diltiazem and verapamil, on thyrotropin- and gonadotropin-releasing hormone-stimulated anterior pituitary hormone secretion in man. J Clin Endocrinol Metab 1985;60(1):144-9
   PubMed Web of Science ®Google Scholar
• Satoh T, Fujita KI, Munakata H, Studies on the interactions between drugs and estrogen: analytical method for prediction system of gynecomastia induced by drugs on the inhibitory metabolism of estradiol using Escherichia coli coexpressing human CYP3A4 with human NADPH-cytochrome P450 reductase. Anal Biochem 2000;286(2):179-86
   PubMed Web of Science ®Google Scholar
• Satoh T, Munakata H, Fujita K, Studies on the interactions between drug and estrogen. II. On the inhibitory effect of 29 drugs reported to induce gynecomastia on the oxidation of estradiol at C-2 or C-17. Biol Pharm Bull 2003;26(5):695-700
   PubMed Web of Science ®Google Scholar
• Satoh T, Tomikawa Y, Takanashi K, Studies on the interactions between drugs and estrogen. III. Inhibitory effects of 29 drugs reported to induce gynecomastia on the glucuronidation of estradiol. Biol Pharm Bull 2004;27(11):1844-9
   PubMed Web of Science ®Google Scholar
• García Rodríguez LA, Jick H. Risk of gynaecomastia associated with cimetidine, omeprazole, and other antiulcer drugs. BMJ 1994;308(6927):503-6
   PubMed Web of Science ®Google Scholar
• Carvajal A, Macias D, Gutiérrez A, Gynaecomastia associated with proton pump inhibitors: a case series from the Spanish Pharmacovigilance System. Drug Saf 2007;30(6):527-31
   PubMed Web of Science ®Google Scholar
• Lindquist M, Edwards IR. Endocrine adverse effects of omeprazole. BMJ 1992;305(6851):451-2
   PubMed Web of Science ®Google Scholar
• Santucci L, Farroni F, Fiorucci S, Gynecomastia during omeprazole therapy. N Engl J Med 1991;324(9):635
   PubMed Web of Science ®Google Scholar
• Piroth L, Grappin M, Petit JM, Incidence of gynecomastia in men infected with HIV and treated with highly active antiretroviral therapy. Scand J Infect Dis 2001;33(7):559-60
   PubMed Web of Science ®Google Scholar
• Peyriere H, Mauboussin JM, Rouanet I, Report of gynecomastia in five male patients during antiretroviral therapy for HIV infection. AIDS 1999;13(15):2167-9
   PubMed Web of Science ®Google Scholar
• Donovan B, Bodsworth NJ, Mulhall BP, Gynaecomastia associated with saquinavir therapy. Int J STD AIDS 1999;10(1):49-50
   PubMed Web of Science ®Google Scholar
• Rahim S, Ortiz O, Maslow M, A case-control study of gynecomastia in HIV-1-infected patients receiving HAART. AIDS Read 2004;14(1):23-4; 29–32, 35–40
   PubMedGoogle Scholar
• Manfredi R, Calza L, Chiodo F. Another emerging event occurring during HIV infection treated with any antiretroviral therapy: frequency and role of gynecomastia. Infez Med 2004;12(1):51-9
   PubMedGoogle Scholar
• Caso JA, Prieto J de M, Casas E, Gynecomastia without lipodystrophy syndrome in HIV-infected men treated with efavirenz. AIDS 2001;15(11):1447-8
   PubMed Web of Science ®Google Scholar
• Qazi NA, Morlese JF, King DM, Gynaecomastia without lipodystrophy in HIV-1-seropositive patients on efavirenz: an alternative hypothesis. AIDS 2002;16(3):506-7
   PubMed Web of Science ®Google Scholar
• Evans DL, Pantanowitz L, Dezube BJ, Breast enlargement in 13 men who were seropositive for human immunodeficiency virus. Clin Infect Dis 2002;35(9):1113-19
   PubMed Web of Science ®Google Scholar
• Imami N, Antonopoulos C, Hardy GA, Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy. AIDS Res Hum Retroviruses 1999;15(17):1499-508
   PubMed Web of Science ®Google Scholar
• Katano M, Matsuo T, Morisaki T, Increased proliferation of a human breast carcinoma cell line by recombinant interleukin-2. Cancer Immunol Immunother 1994;39(3):161-6
   PubMed Web of Science ®Google Scholar
• Singh A, Purohit A, Ghilchik MW, The regulation of aromatase activity in breast fibroblasts: the role of interleukin-6 and prostaglandin E2. Endocr Relat Cancer 1999;6(2):139-47
   PubMed Web of Science ®Google Scholar
• Forest MG, Lecoq A, Saez JM. Kinetics of human chorionic gonadotropin-induced steroidogenic response of the human testis. II. Plasma 17 alpha-hydroxyprogesterone, delta4-androstenedione, estrone, and 17 beta-estradiol: evidence for the action of human chorionic gonadotropin on intermediate enzymes implicated in steroid biosynthesis. J Clin Endocrinol Metab 1979;49(2):284-91
   PubMed Web of Science ®Google Scholar
• Trump DL, Anderson SA. Painful gynecomastia following cytotoxic therapy for testis cancer: a potentially favorable prognostic sign? J Clin Oncol 1983;1(7):416-20
   PubMed Web of Science ®Google Scholar
• Tseng A Jr, Horning SJ, Freiha FS, Gynecomastia in testicular cancer patients. Prognostic and therapeutic implications. Cancer 1985;56(10):2534-8
   PubMed Web of Science ®Google Scholar
• Turner AR, Morrish DW, Berry J, Gynecomastia after cytotoxic therapy for metastatic testicular cancer. Arch Intern Med 1982;142(5):896-7
   PubMed Web of Science ®Google Scholar
• Schorer AE, Oken MM, Johnson GJ. Gynecomastia with nitrosourea therapy. Cancer Treat Rep 1978;62(4):574-6
   PubMedGoogle Scholar
• Large DM, Jones JM, Shalet SM, Gynaecomastia complicating the treatment of myeloma. Br J Cancer 1983;48(1):69-74
   PubMed Web of Science ®Google Scholar
• Sherins RJ, Olweny CL, Ziegler JL. Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease. N Engl J Med 1978;299(1):12-16
   PubMed Web of Science ®Google Scholar
• Glass AR, Berenberg J. Gynecomastia after chemotherapy for lymphoma. Arch Intern Med 1979;139(9):1048-9
   PubMed Web of Science ®Google Scholar
• Saeter G, Fosså SD, Norman N. Gynaecomastia following cytotoxic therapy for testicular cancer. Br J Urol 1987;59(4):348-52
   PubMedGoogle Scholar
• Schilsky RL, Lewis BJ, Sherins RJ, Gonadal dysfunction in patients receiving chemotherapy for cancer. Ann Intern Med 1980;93(1):109-14
   PubMed Web of Science ®Google Scholar
• Evans NA. Gym and tonic: a profile of 100 male steroid users. Br J Sports Med 1997;31(1):54-8
   PubMed Web of Science ®Google Scholar
• Korkia P, Stimson GV. Indications of prevalence, practice and effects of anabolic steroid use in Great Britain. Int J Sports Med 1997;18(7):557-62
   PubMed Web of Science ®Google Scholar
• Pope HG Jr, Katz DL. Psychiatric and medical effects of anabolic-androgenic steroid use. A controlled study of 160 athletes. Arch Gen Psychiatry 1994;51(5):375-82
   PubMed Web of Science ®Google Scholar
• Brown GA, Vukovich MD, Martini ER, Endocrine responses to chronic androstenedione intake in 30- to 56-year-old men. J Clin Endocrinol Metab 2000;85(11):4074-80
   PubMed Web of Science ®Google Scholar
• Leder BZ, Longcope C, Catlin DH, Oral androstenedione administration and serum testosterone concentrations in young men. JAMA 2000;283(6):779-82
   PubMed Web of Science ®Google Scholar
• Calzada L, Torres-Calleja J, Martinez JM, Measurement of androgen and estrogen receptors in breast tissue from subjects with anabolic steroid-dependent gynecomastia. Life Sci 2001;69(13):1465-9
   PubMed Web of Science ®Google Scholar
• Boyden TW, Pamenter RW. Effects of ethanol on the male hypothalamic-pituitary-gonadal axis. Endocr Rev 1983;4(4):389-95
   PubMed Web of Science ®Google Scholar
• Adler RA. Clinical review 33: clinically important effects of alcohol on endocrine function. J Clin Endocrinol Metab 1992;74(5):957-60
   PubMed Web of Science ®Google Scholar
• Van Thiel DH, Cobb CF, Herman GB, An examination of various mechanisms for ethanol-induced testicular injury: studies utilizing the isolated perfused rat testes. Endocrinology 1981;109(6):2009-15
   PubMed Web of Science ®Google Scholar
• Gavaler JS. Alcoholic beverages as a source of estrogens. Alcohol Health Res World 1998;22(3):220-7
   PubMed Web of Science ®Google Scholar
• Cicero TJ, Bell RD, Wiest WG, Function of the male sex organs in heroin and methadone users. N Engl J Med 1975;292(17):882-7
   PubMed Web of Science ®Google Scholar
• Mendelson JH, Meyer RE, Ellingboe J, Effects of heroin and methadone on plasma cortisol and testosterone. J Pharmacol Exp Ther 1975;195(2):296-302
   PubMed Web of Science ®Google Scholar
• Thomas BL. Letter: methadone-associated gynecomastia. N Engl J Med 1976;294(3):169
   PubMed Web of Science ®Google Scholar
• de la Rosa RE, Hennessey JV. Hypogonadism and methadone: hypothalamic hypogonadism after long-term use of high-dose methadone. Endocr Pract 1996;2(1):4-7
   PubMedGoogle Scholar
• Bliesener N, Albrecht S, Schwager A, Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence. J Clin Endocrinol Metab 2005;90(1):203-6
   PubMed Web of Science ®Google Scholar
• Margolis IB, Gross CG. Gynecomastia during phenothiazine therapy. JAMA 1967;199(12):942-4
   PubMed Web of Science ®Google Scholar
• Shader RI, DiMascio A. Endocrine effects of psychotropic drugs. 1. Galactorrhea and gynecomastia. Conn Med 1968;32(2):106-8
   PubMedGoogle Scholar
• Kaneda Y, Fujii A. Gynecomastia with sulpiride. J Clin Pharm Ther 2002;27(1):75-7
   PubMed Web of Science ®Google Scholar
• Storch DD. Gynecomastia with antipsychotics. J Am Acad Child Adolesc Psychiatry 1997;36(2):161-2
   PubMed Web of Science ®Google Scholar
• Haddad PM, Wieck A. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management. Drugs 2004;64(20):2291-314
   PubMed Web of Science ®Google Scholar
• Boulenger A, Viseux V, Plantin-Eon I, Gynaecomastia following treatment by fluoxetine. J Eur Acad Dermatol Venereol 2003;17(1):109
   PubMed Web of Science ®Google Scholar
• Sahin M, Yilmaz H, Guvener ND. A possible case of gynecomastia with fluoxetine. Ann Pharmacother 2005;39(7-8):1369
   PubMed Web of Science ®Google Scholar
• Benazzi F. Gynecomastia with risperidone-fluoxetine combination. Pharmacopsychiatry 1999;32(1):41
   PubMed Web of Science ®Google Scholar
• Damsa C, Sterck R, Schulz P. Case of gynecomastia during paroxetine therapy. J Clin Psychiatry 2003;64(8):971
   PubMed Web of Science ®Google Scholar
• Karakurt F, Kargili A, Uz B, Venlafaxine-induced gynecomastia in a young patient: a case report. Clin Neuropharmacol 2009;32(1):51-2
   PubMed Web of Science ®Google Scholar
• Jelenkovic AV, Macukanovic-Golubovic LD. Diazepam-associated gynecomastia. Ann Pharmacother 2005;39(1):201
   PubMed Web of Science ®Google Scholar
• Bergman D, Futterweit W, Segal R, Increased oestradiol in diazepam related gynaecomastia. Lancet 1981;2(8257):1225-6
   PubMed Web of Science ®Google Scholar
• Monson JP, Scott DF. Gynaecomastia induced by phenytoin in men with epilepsy. Br Med J (Clin Res Ed) 1987;294(6572):612
   PubMed Web of Science ®Google Scholar
• Ikeda A, Hattori H, Odani A, Gynaecomastia in association with phenytoin and zonisamide in a patient having a CYP2C subfamily mutation. J Neurol Neurosurg Psychiatr 1998;65(5):803-4
   PubMed Web of Science ®Google Scholar
• Málaga I, Sanmarti FX. Two cases of painful gynecomastia and lower extremity pain in association with pregabalin therapy. Epilepsia 2006;47(9):1576-9
   PubMed Web of Science ®Google Scholar
• Zylicz Z. Painful gynecomastia: an unusual toxicity of gabapentin? J Pain Symptom Manage 2000;20(1):2-3
   PubMed Web of Science ®Google Scholar
• Cornes PG, Hole AC. Amlodipine gynaecomastia. Breast 2001;10(6):544-5
   PubMed Web of Science ®Google Scholar
• Zochling J, Large G, Fassett R. Gynaecomastia and amlodipine. Med J Aust 1994;160(12):807
   PubMed Web of Science ®Google Scholar
• Markusse HM, Meyboom RH. Gynaecomastia associated with captopril. Br Med J (Clin Res Ed) 1988;296(6631):1262-3
   PubMed Web of Science ®Google Scholar
• Nakamura Y, Yoshimoto K, Saima S. Gynaecomastia induced by angiotensin converting enzyme inhibitor. BMJ 1990;300(6723):541
   PubMed Web of Science ®Google Scholar
• Antonelli D, Luboshitzky R, Gelbendorf A. Amiodarone-induced gynecomastia. N Engl J Med 1986;315(24):1553
   PubMed Web of Science ®Google Scholar
• Lewinn EB. Gynecomastia during digitalis therapy; report of eight additional cases with liver-function studies. N Engl J. Med 1953;248(8):316-20
   PubMed Web of Science ®Google Scholar
• Dall JL. Digitalis Intoxication in elderly patients. Lancet 1965;1(7378):194-5
   PubMed Web of Science ®Google Scholar
• Singer EP. Gynecomastia following digitalis administration. J Med Soc N J 1967;64(10):557-9
   PubMedGoogle Scholar
• Stoffer SS, Hynes KM, Jiang NS, Digoxin and abnormal serum hormone levels. JAMA 1973;225(13):1643-4
   PubMed Web of Science ®Google Scholar
• Burckhardt D, Vera CA, LaDue JS. Effect of digitalis on urinary pituitary gonadotropin excretion. A study in postmenopausal women. Ann Intern Med 1968;68(5):1069-71
   PubMed Web of Science ®Google Scholar
• Aerts J, Karmochkine M, Raguin G. [Gynecomastia due to pravastatin]. Presse Med 1999;28(15):787
   PubMed Web of Science ®Google Scholar
• Hammons KB, Edwards RF, Rice WY. Golf-inhibiting gynecomastia associated with atorvastatin therapy. Pharmacotherapy 2006;26(8):1165-8
   PubMed Web of Science ®Google Scholar
• Oteri A, Catania MA, Travaglini R, Gynecomastia possibly induced by rosuvastatin. Pharmacotherapy 2008;28(4):549-51
   PubMed Web of Science ®Google Scholar
• Gardette V, Vezzosi D, Maiza J-C, Gynecomastia associated with fenofibrate. Ann Pharmacother 2007;41(3):508-10
   PubMed Web of Science ®Google Scholar
• Tosi S, Cagnoli M. Painful gynecomastia with ranitidine. Lancet 1982;2(8290):160
   PubMed Web of Science ®Google Scholar
• Madani S, Tolia V. Gynecomastia with metoclopramide use in pediatric patients. J Clin Gastroenterol 1997;24(2):79-81
   PubMed Web of Science ®Google Scholar
• Keating JP, Rees M. Gynaecomastia after long-term administration of domperidone. Postgrad Med J 1991;67(786):401-2
   PubMed Web of Science ®Google Scholar
• van der Steen M, Du Caju MV, Van Acker KJ. Gynecomastia in a male infant given domperidone. Lancet 1982;2(8303):884-5
   PubMed Web of Science ®Google Scholar
• Soykan I, Sarosiek I, McCallum RW. The effect of chronic oral domperidone therapy on gastrointestinal symptoms, gastric emptying, and quality of life in patients with gastroparesis. Am J Gastroenterol 1997;92(6):976-80
   PubMed Web of Science ®Google Scholar
• Garg R, Vaibhav Mehra S, Isoniazid induced gynaecomastia: a case report. Indian J Tuberc 2009;56(1):51-4
   PubMedGoogle Scholar
• Khanna P, Panjabi C, Maurya V, Isoniazid associated, painful, bilateral gynaecomastia. Indian J Chest Dis Allied Sci 2003;45(4):277-9
   PubMedGoogle Scholar
• Dixit R, Sharma S, Nawal CL. Gynaecomastia during antituberculosis chemotherapy with isoniazid. J Assoc Phys India 2008;56:390-1
   PubMedGoogle Scholar
• Morrone N, Morrone Junior N, Braz AG, Gynecomastia: a rare adverse effect of isoniazid. J Bras Pneumol 2008;34(11):978-81
   PubMedGoogle Scholar
• Davies JP, Price-Thomas JM. Gynaecomastia in association with minocycline. Br J Clin Pract 1995;49(4):179
   PubMedGoogle Scholar
• Fagan TC, Johnson DG, Grosso DS. Metronidazole-induced gynecomastia. JAMA 1985;254(22):3217
   PubMed Web of Science ®Google Scholar
• Del Paine DW, Leek JC, Jakle C, Gynecomastia associated with low dose methotrexate therapy. Arthritis Rheum 1983;26(5):691-2
   PubMed Web of Science ®Google Scholar
• Thomas E, Leroux JL, Blotman F. Gynecomastia in patients with rheumatoid arthritis treated with methotrexate. J Rheumatol 1994;21(9):1777-8
   PubMed Web of Science ®Google Scholar
• Finger DR, Klipple GL. Gynecomastia following low dose methotrexate therapy for rheumatoid arthritis. J Rheumatol 1995;22(4):796-7
   PubMed Web of Science ®Google Scholar
• Aguirre MA, Vélez A, Romero M, Gynecomastia and sexual impotence associated with methotrexate treatment. J. Rheumatol 2002;29(8):1793-4
   PubMed Web of Science ®Google Scholar
• Pandhi D, Gupta R, Singal A. Gynaecomastia with oligospermia: an unusual complication of low-dose methotrexate for pustular psoriasis. Clin Exp Dermatol 2006;31(1):138-40
   PubMed Web of Science ®Google Scholar
• Pulik M, Genet P, Lionnet F, Thalidomide-associated gynecomasty in a patient with multiple myeloma. Am J Hematol 2002;70(3):265
   PubMed Web of Science ®Google Scholar
• Iaria G, Urbani L, Catalano G, Switch to tacrolimus for cyclosporine-induced gynecomastia in liver transplant recipients. Transplant Proc 2005;37(6):2632-3
   PubMed Web of Science ®Google Scholar
• Harmon J, Aliapoulios MA. Gynecomastia in marihuana users. N Engl J Med 1972;287(18):936
   PubMed Web of Science ®Google Scholar
• Olusi SO. Hyperprolactinaemia in patients with suspected cannabis-induced gynaecomastia. Lancet 1980;1(8162):255
   PubMed Web of Science ®Google Scholar
• Allen RC, Wallace AM, Royce M. Marinol-induced gynecomastia: a case report. Am J Med 2007;120(10):e1
   Google Scholar
• Sauer MA, Rifka SM, Hawks RL, Marijuana: interaction with the estrogen receptor. J Pharmacol Exp Ther 1983;224(2):404-7
   PubMed Web of Science ®Google Scholar
• Tooley PH, Lack C. Gynecomastia during treatment with amphetamine. Lancet 1949;1(6555):650
   PubMedGoogle Scholar
• Dardick KR. Gynecomastia associated with theophylline. J Fam Pract 1984;18(1):141-2
   PubMed Web of Science ®Google Scholar
• Mendhekar DN. Clonidine-induced gynecomastia and hyperprolactinemia in a 6-year-old child. J Clin Psychiatry 2005;66(12):1616-17
   PubMed Web of Science ®Google Scholar
• Reid DM, Martynoga AG, Nuki G. Reversible gynaecomastia associated with D-penicillamine in a man with rheumatoid arthritis. Br Med J (Clin Res Ed) 1982;285(6348):1083-4
   PubMed Web of Science ®Google Scholar
• Roberts HJ. Vitamin E and gynecomastia. Hosp Pract (Off. Ed.) 1994;29(1):12
   PubMed Web of Science ®Google Scholar
• De Bleecker JL, Lamont BH, Verstraete AG, Melatonin and painful gynecomastia. Neurology 1999;53(2):435-6
   PubMed Web of Science ®Google Scholar
• Bridgman JF, Buckler JM. Letter: drug-induced gynaecomastia. Br Med J 1974;3(5929):520-1
   PubMedGoogle Scholar
• Jameel JKA, Kneeshaw PJ, Rao VSR, Gynaecomastia and the plant product “Tribulis terrestris”. Breast 2004;13(5):428-30
   PubMed Web of Science ®Google Scholar
• Sahin M, Yilmaz H, Gursoy A, Gynaecomastia in a man and hyperoestrogenism in a woman due to ingestion of nettle (Urtica dioica). NZ Med J 2007;120(1265):U2803
   Google Scholar
• Henley DV, Lipson N, Korach KS, Prepubertal gynecomastia linked to lavender and tea tree oils. N Engl J Med 2007;356(5):479-85
   PubMed Web of Science ®Google Scholar
• Martinez J, Lewi JE. An unusual case of gynecomastia associated with soy product consumption. Endocr Pract 2008;14(4):415-18
   PubMedGoogle Scholar